comparemela.com

Latest Breaking News On - Meningococcal disease caused - Page 1 : comparemela.com

GSK : presents pivotal data at ESPID confirming effectiveness of its 5-in-1 meningococcal ABCWY vaccine candidate, with demonstrated coverage against a panel of 110 MenB strains

Preliminary results from phase III trial show all primary endpoints met, demonstrating statistical non-inferiority compared to Bexsero and Menveo , in individuals 10-25 years old with. | May 12, 2023

United statesCzech republicBexsero menTerry nolanBing wangTony woodMenveo menImmunisation research groupUniversity of melbournePeter doherty institute for infectionNational immunizationNational vaccination coverage among adolescentsMurdoch children research instituteRepresentative panelAnnual meetingEuropean society

GSK : presents pivotal data at ESPID confirming effectiveness of its 5-in-1 meningococcal ABCWY vaccine candidate, with demonstrated coverage against a panel of 110 MenB strains - Form 6-K

GSK presents pivotal data at ESPID confirming effectiveness of its 5-in-1 meningococcal ABCWY vaccine candidate, with demonstrated coverage against a panel of 110 MenB strains . | May 12, 2023

City ofUnited kingdomUnited kingdom generalUnited statesCzech republicMick readeyJosh williamsSteph mountifieldJames dodwellTerry nolanSimon mooreTim foleyKathleen quinnCamilla campbellTony woodJeff mclaughlin

vimarsana © 2020. All Rights Reserved.